Cell and gene therapies (CGT) have been transformative for the treatment several diseases, particularly haematological cancers and genetic conditions like sickle cell disease, with many new indications in the pipeline.

This eBook, sponsored by Oxford Nanopore Technologies, explores the latest developments in advanced therapies, which treatments are securing industry investment, and the challenges and opportunities of a changing regulatory landscape.

Download this exclusive eBook to learn more about:  

• How next-gen preclinical models can transform cell and gene therapies
• Gene-agnostic therapies for inherited retinal diseases
• The role of AI in breaking barriers to CGT success
• How we can revolutionise cancer treatment with viral vectors